ASArifin Seweng

Arifin Seweng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Arifin Seweng has a total of 59 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Determinants of survival time in patients with sepsis: A cross-sectional study

    by Giordano Bandi-Lolok, Risna Mubin, Harun Iskandar, Haerani Rasyid, Syakib Bakri, Satriawan Abadi, Arifin Seweng

    Background/Aim: Sepsis remains a major cause of in-hospital mortality and early outcomes may depend on comorbidity, infection characteristics and treatment. The aim was to examine demographic, clinical and microbiological factors associated with survival time (≤ 7 versus > 7 days) in patients with sepsis. Methods: This retrospective cross-sectional study used the records of adults diagnosed with sepsis at a tertiary referral hospital. Demographic variables, Charlson Comorbidity Index (CCI), infection source, microbiological findings, antimicrobial resistance and antibiotic appropriateness were recorded. The outcome was categorised as survival time of ≤ 7 or > 7 days. Variables significant in bivariate analyses were entered into stepwise multivariable logistic regression. Results: Among 143 patients, 62 (43.4 %) were in the ≤ 7-day group and 81 (56.6 %) in the > 7-day group. In the final model, CCI ≥ 5 (odds ratio [OR] 3.02, 95 % confidence interval [CI] 1.38-6.65; p = 0.006) and antimicrobial resistance (OR 8.00, 95 % CI 3.19-19.45; p < 0.001) were associated with greater odds of the ≤ 7-day outcome. Methicillin-resistant Staphylococcus aureus (MRSA), extended-spectrum beta-lactamase (ESBL) production and ceftriaxone resistance were not statistically significant in the final model. Appropriate antibiotic therapy was associated with lower odds in bivariate analysis but was not retained in the final model. Conclusion: Higher comorbidity burden and antimicrobial resistance were associated with the ≤ 7-day outcome in this cohort. Although appropriate antibiotic therapy was associated with the outcome in bivariate analysis, an independent association was not demonstrated in the final model. These findings support further evaluation of comorbidity and resistance profiles in early risk assessment.

  • Open Access

    Correlation of serum fibroblast growth factor-23 levels and calcium phosphate products levels in chronic kidney disease; sub analysis of chronic kidney disease-mineral and bone disorder study

    by Adeh Mahardika, Hasyim Kasim, Syakib Bakri, Haerani Rasyid, Husaini Umar, Nu’mAn As Daud, Wasis Udaya, Arifin Seweng

    Introduction: The body produces fibroblast growth factor-23 (FGF-23) to maintain normal phosphate levels when hyperphosphatemia occurs. Production of FGF-23 indirectly causes hypocalcemia. Phosphate and calcium disturbances also occur in chronic kidney disease (CKD), therefore this adaptation mechanism applies. This situation; however, only manifests in the early stages of CKD; if the estimated glomerular filtration rate (eGFR) is less than 30% of normal. This adaptation is no longer adequate and levels of calcium-phosphate (Ca×P) products and FGF-23 still rise. Objectives: In this study, the correlation between both the serum levels of FGF-23 and Ca×P products in CKD was analyzed. Patients and Methods: A cross-sectional study including 78 subjects with CKD stages 3 to 5 dialysis was conducted. Serum FGF-23 levels were determined using the enzyme-linked immunosorbent assay (ELISA) method and Ca×P product levels were calculated using the formula calcium (mg/ dL) × phosphate (mg/dL). The Kolmogorov-Smirnov test and Spearman’s test were conducted in the statistical study. If the P value is less than 0.05, the statistical findings are significant. Results: Serum FGF-23 levels and Ca×P product levels were shown to be significantly correlated. This analysis of the two correlations was independent of age and diabetes mellitus (DM). Based on stages of CKD, serum FGF-23 levels and Ca×P product levels were discovered to be significantly correlated only at stage 5 of non-dialysis. Conclusion: Increasing serum FGF-23 levels were correlated with increased Ca×P product levels, particularly in CKD stage 5 non-dialysis subjects. This correlation was independent of age and DM.


  • Open Access

    Relationship between fibroblast growth factor 23 level and vitamin D status in chronic kidney disease: A cross-sectional study

    by Andi Puspa Ratu, Haerani Rasyid, Syakib Bakri, Andi Makbul Aman Mansyur, Harun Iskandar, Arifin Seweng

    Complications stemming from chronic kidney disease (CKD) significantly contribute to increased morbidity and mortality rates. During the early stages of CKD, a delicate balance in homeostasis and mineral regulation is maintained largely due to fibroblast growth factor 23 (FGF-23). However, as kidney function declines, there is a detrimental effect on vitamin D synthesis. Understanding the dynamics of FGF-23 levels in relation to vitamin D status is crucial for assessing kidney function and its implications on hormonal regulation, calcium homeostasis, and cardiovascular health. Therefore, this study aimed to scrutinize and comprehend the correlation between FGF-23 levels and vitamin D status in patients afflicted with CKD. Methods. A cross-sectional study was undertaken at Dr. Wahidin Sudirohusodo Hospital in Makassar, South Sulawesi, Indonesia, involving 58 patients diagnosed with stage 3-5 non-dialysis CKD. Relationships between FGF-23 level with vitamin D level status and CKD stage were analyzed by chi-square and Kruskal-Wallis test. Results. The FGF-23 levels, with a median of 100 pg/mL as the designated cut-off, exhibit significance concerning the levels of vitamin D (p=0.003). The average values of FGF-23 in cases of deficiency and insufficiency are markedly elevated when compared to patients with sufficient vitamin D levels (p=0.016). The significance of FGF-23 levels becomes more prominent with advancing CKD stages (p=0.06). Conclusions. FGF-23 is a related marker with vitamin D deficiency in patients with CKD but is inconsistent in stage development and not an independent factor.

  • Open Access

    The correlation between serum fibroblast growth factor-23 levels and left ventricular hypertrophy in chronic kidney disease patients

    by Abdul Mubdi Aa Karim, Hasyim Kasim, Akhyar Albaar, Sitti Rabiul Zatalia Ramadhan, Nasrum Machmud, Haerani Rasyid, Pendrik Tandean, Syakib Bakri, Erwin Arief, Tutik Harjianti, et al.

    Introduction: Hyperphosphatemia in chronic kidney disease (CKD) patients can stimulate the production of the fibroblast growth factor-23 (FGF-23) phosphatonin hormone, which is associated with cardiac remodeling resulting in left ventricular hypertrophy (LVH). Objectives: To determine the correlation between FGF-23 level and LVH incidence in CKD patients and establish the associated risk factors. Materials and Methods: This cross-sectional study involved 74 CKD patients who were classified as stage 3 (n=18), stage 4 (n=17), stage 3 (n=18), dialysis stage 5 (n=20), or non-dialysis stage 5 (n=19). The FGF-23 levels of the patients were measured using the ELISA (enzyme-linked immunosorbent assay) kit method, whereas a cardiologist verified LVH using an echocardiographic examination based on the LVH criteria of >95 g/m2 for females and >115 g/m2 for males. Results: A significant difference was observed in the mean FGF-23 values between the LVH and non-LVH patients (443.27±437.047 RU/mL and 172.68±185.56 RU/mL, respectively; P123.95 RU/mL had a 3.6 times greater risk of LVH compared to those with values ≤123.95 RU/mL. The LVH risk factors of gender and age, as well as hypertension, diabetes mellitus, and obesity diagnoses were not associated with LVH incidence in CKD patients. Conclusion: A significant association was found between FGF-23 level and LVH incidence in CKD patients, in which an FGF-23 level >123.95 RU/mL corresponded to a 3.6 times greater risk of LVH than those with FGF-23 levels below this value.

  • Open Access

    Intravenous Granisetron Combined with Dexamethasone in Cesarean Section Patients Undergoing Spinal Anesthesia

    by Syafruddin Gaus, Irfan Faisal Sjattar, Andi Salahuddin, Muhammad Ramli Ahmad, Nur Surya Wirawan, Arifin Seweng

    BACKGROUND: Regional anesthesia, including spinal anesthesia, is the technique-of-choice over general anesthesia for cesarean section (C-section). Nausea, vomiting, and shivering are common after spinal anesthesia. Granisetron and dexamethasone are used as a premedication to prevent these reactions. AIM: This study determined the effect of different doses of granisetron combined with dexamethasone for the prevention of nausea, vomiting, and shivering. PATIENTS AND METHODS: This double-blind randomized clinical trial included patients undergoing C-section under spinal anesthesia at several hospitals in Makassar, Indonesia. Forty-five cases were divided into three equal-sized groups: G5, administered intravenous (IV) granisetron at 5 mcg/kg body weight (BW); G10, administered IV granisetron at 10 mcg/kgBW; and G25, administered IV granisetron at 25 mcg/kgBW. All patients also received IV dexamethasone at 0.1 mg/kgBW. RESULTS: In the G10 group, three cases experienced mild nausea, while, in the G5 and G25 groups, there were no incidences of nausea; this was a statistically significant difference (p = 0.043). Vomiting was not reported in any group. The G25 group had the lowest number of patients experiencing shivering (one case with a score of 3), but there were no significant differences in shivering incidence between groups (p = 0.164). CONCLUSION: Granisetron is effective in reducing nausea and shivering at certain dosage.


  • Open Access

    Vitamin D Serum Level in Elderly: Its Association with The Incidence and Degree of Sarcopenia

    by Niza Amalya, Wasis Udaya, Agus Sudarso, Syakib Bakri, Haerani Rasyid, Hasyim Kasim, Muh. Ilyas, Arifin Seweng

  • Open Access

    Correlation of glomerular filtration rate and fibroblast growth factor-23 levels in chronic kidney disease; sub analysis chronic kidney disease–mineral and bone disorder study

    by Akiko Syawalidhany Tahir, Haerani Rasyid, Syakib Bakri, Hasyim Kasim, Tutik Harjianti, Muhammad Luthfi Parewangi, Harun Iskandar, Arifin Seweng, Resha Dermawansyah Rusman

    Introduction: One of the chronic kidney disease (CKD) manifestations is mineral disorder, such as phosphate and calcium. Phosphatonin levels are regulated by the hormone phosphatonin, which the most commonly associated with CKD is fibroblast growth factor-23 (FGF-23), mainly synthesized by bone cells. The increase in FGF-23 in CKD subjects is a physiological response to stabilize phosphate levels. Several conditions can increase FGF-23 levels including age, body mass index (BMI), diabetes mellitus (DM), and hypertension. Objectives: This study aims to test the correlation between FGF-23 levels at various stages of glomerular filtration rate (GFR) in CKD. Patients and Methods: This study is observational with a cross-sectional approach conducted at Wahidin Sudirohusodo and Unhas hospitals of Makassar. Subjects are CKD patients which meet inclusion criteria. Intact serum FGF-23 levels were measured using an ELISA (enzyme-linked immunosorbent assay) kit (Immutopics). Statistical analysis was conducted using ANOVA test, Mann-Whitney U, and Spearman’s correlation tests. Statistical results are considered significant if P<0.05. Results: The research was conducted on 78 subjects with CKD stages 3, 4 and 5, which consisted of 40 men and 38 women. The correlation test showed that the lower the GFR, the higher the FGF-23 level (P0.05). Conclusion: We found that every increase in the CKD stages and decrease of GFR, would be associated with an increase in the plasma levels of FGF-23. However, FGF-23 plasma concentration had no significant correlation with age, BMI, DM, and hypertension.


  • Open Access

    Proportions of hyperphosphatemia in different stages of chronic kidney disease

    by Akbar Iskandar, Haerani Rasyid, Syakib Bakri, Hasyim Kasim, Andi Makbul Aman, Femy Syahriani, Nu’mAn As Daud, Arifin Seweng

    Introduction: In chronic kidney disease (CKD) patients, calcium and phosphate homeostasis disorders occur. Decreased kidney function will result in decreased phosphate excretion. In stage 3b CKD, the kidneys are no longer able to compensate for the phosphate load sufficiently and hyperphosphatemia is resulted. Objectives: This research aimed to figure out the proportions of hyperphosphatemic patients at different levels of glomerular filtration rate in CKD. Patients and Methods: An observational study with a cross-sectional approach involving 80 CKD subjects, distributed into stage 3 (n = 20), stage 4 (n = 20), stage 5 non-dialysis (n = 20) and stage 5 dialysis CKD subjects(n = 20), at Wahidin Sudirohusodo hospital and Unhas hospital, Makassar, from April through August 2021. Phosphate concentrations were measured using ELISA (enzyme-linked immunosorbent assay) kit (Immutopics). A result of the statistical test would be significant if P < 0.05. Results: The average phosphate concentrations at stage 3, stage 4, stage 5 non-dialysis and stage 5 dialysis were 4.14 ± 1.85 mg/dL, 4.17 ± 1.12 mg/dL, 6.43 ± 3.09 md/dL and 5.42 ± 3.09 mg/dL, respectively. Based on the avergae phosphate concentration by CKD stage, stage 3 was not significantly different from stage 4 (P = 0.969), however there was a significant difference between stage 3 and stage 5 non-dialysis (P = 0.004) and also between stage 4 and stage 5 non-dialysis (P = 0.005). The proportions of hyperphosphatemic patients (serum phosphate >4.5 mg/dL) with stage 3, stage 4, stage 5 non-dialysis and stage 5 dialysis CKD were 15% (n = 3), 20% (n = 4), 75% (n = 15) and 43.3% (n = 9), respectively. Conclusion: The porportion of hyperphosphatemic subjects increased with the decline in the kidney function. Dialysis process reduces phosphate levels and the proportion of patients with hyperphosphatemia.

  • Open Access

    Gambaran Radiologik Pneumonia pada Anak dengan Menggunakan Foto Thorax dan Ultrasonografi Paru di Rumah Sakit Wahidin Sudirohusodo Makassar

    by Jeri J, Sri Asriyani, Amiruddin L, Arifin Seweng

    Pendahuluan Pneumonia menjadi penyebab utama kematian pada anak di bawah usia 5 tahun selama beberapa dekade. Foto X-ray dada adalah modalitas diagnostik yang paling umum digunakan. Namun, karena efek radiasi sinar-X, ultrasonografi menjadi semakin populer untuk diagnosis pneumonia pada anak-anak. Penelitian ini bertujuan untuk membandingkan dan menilai kesesuaian (agreement) antara hasil pemeriksaan x-ray dada dan ultrasonografi untuk diagnosis pneumonia pada anak-anak. Metode: Penelitian ini dilakukan di Bagian Radiologi Rumah Sakit Umum Pusat Dr. Wahidin Sudirohusodo Makassar dan Rumah Sakit Pendidikan Universitas Hasanuddin Makassar dari bulan Februari sampai April 2020. Jumlah sampel sebanyak 44 pasien berusia antara 1 hari sampai kurang dari 18 tahun. Tes Kappa digunakan untuk menilai kesesuaian antara kedua metode. Hasil: Hasil penelitian menunjukkan bahwa gambaran pneumonia pada anak berdasarkan hepatisasi pada USG paru menunjukkan kesesuaian yang signifikan dengan tanda konsolidasi pada foto thorax (koefisien Kappa = 0,560, p <0,05). Elemen hyperechoic linier pada ultrasonografi paru dengan tanda air bronchogram dan infiltrat pada foto toraks juga menunjukkan kesesuaian yang baik (koefisien Kappa = 0,596, p <0,05). Selain itu, tanda lesi anechoic pada ultrasonografi paru dengan gambar ground glass opacity (GGO) pada radiografi dada menghasilkan koefisien Kappa 0,495 dan p <0,05. Kesimpulan: Pneumonia pediatrik dimanifestasikan pada ultrasonografi sebagai hepatisasi, hyperechoic linear elements, dan pathologic B-line, sedangkan pada rontgen dada dimanifestasikan sebagai konsolidasi dan infiltrat. Kesepakatan yang baik ditemukan antara konsolidasi x-ray dengan hepatisasi pada ultrasonografi, antara elemen hyperechoic linier pada ultrasonografi dengan infiltrat pada x-ray, serta antara lesi anechoic pada ultrasonografi dengan GGO pada rontgen dada

  • Open Access

    Sexual behavior influence against HIV/AIDS in homosexuals at Palu City in 2020

    by Jenefri Maharani, Arifin Seweng, Muhammad Sabir, Muhammad Tahir, Stang, Indar Indar, Rosmala Nur